BioLine Rx Q2 EPS $(0.01) Beats $(0.15) Estimate
BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.15) by 93.33 percent. This is a 66.67 percent increase over losses of $(0.03) per share from the
Earnings Scheduled For August 18, 2021
Companies Reporting Before The Bell
• Digital Ally (NASDAQ:DGLY) is likely to report quarterly loss at $0.04 per share on revenue of $2.70 million.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded at a volume of 379 shares come close, making up 0.45% of its average volume over the last 100 days. The company's market cap stands at $87.4 million.
56 Biggest Movers From Friday
Gainers
Sequential Brands Group, Inc. (NASDAQ: SQBG) jumped 89.2% to settle at $15.70.
20 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434 Phase 2 clinical trial.
Earnings Scheduled For May 26, 2021
Companies Reporting Before The Bell
• Boqii Holding (NYSE:BQ) is expected to report quarterly loss at $0.14 per share on revenue of $35.05 million.